Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marine Nanofiber is a Japanese biotechnology company that specializes in the production and application of chitin nanofibers derived from crab shells. Spun off from Tottori University, the company utilizes a proprietary manufacturing process to create ultra-fine fibers that possess high biocompatibility, anti-inflammatory properties, and skin-protective effects. Their technology is applied across various sectors including cosmetics, medical supplies, and functional foods. In the medical field, the company focuses on wound dressings and treatments for skin conditions like atopic dermatitis. Marine Nanofiber aims to leverage sustainable marine resources to provide innovative solutions for human health and skincare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marine Nanofiber.